Evidence map›Paper›PMID 31468376›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H Falk, Victor A Ferrari, Marianna Fontana, Olivier Gheysens, Julian D Gillmore, Andor W J M Glaudemans and 16 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readNews
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06469372 (Cardiac Amyloidosis Discovery Trial), which is not on this map. Cited by 178 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed, 4 pooled it
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06469372 nacompletednot on this mapstarted 2024, after this paper: background citation

Cardiac Amyloidosis Discovery Trial

TypeinterventionalSponsorPierre EliasRan2024 to 2025Enrolled50ConditionsCardiac AmyloidosisArmsCardiac amyloidosis deep learning model
3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 4 syntheses or guidelines pooled it, 459 citations in OpenAlex.

  1. Guideline
  2. EANM practice guideline for quantitative SPECT-CT.European journal of nuclear medicine and molecular imaging · 2023
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pre-symptomatic scintigraphic and genetic cascade screening in cardiac transthyretin amyloidosis.European journal of nuclear medicine and molecular imaging · 2025
    Trial
  6. Trial
  7. Cardiac amyloidosis: what every interventional cardiologist should know.Cardiovascular intervention and therapeutics · 2026
    Review
  8. Article
  9. Article
  10. Synthetic Echocardiograms from Diffusion Models in Rare Cardiovascular Disease.medRxiv : the preprint server for health sciences · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Direct comparison uptake patterns ofJapanese journal of radiology · 2026
    Article
  16. Article
  17. A Nondiagnostic 99mTc-PYP Scan with Absent Skeletal Uptake.Diagnostics (Basel, Switzerland) · 2026
    Article
  18. Article
  19. Article
  20. Article

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 7 countries.

Sharmila DorbalaCardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. sdorbala@bwh.harvard.edu.
Yukio AndoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Sabahat BokhariColumbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, NY, USA.
Angela DispenzieriDivision of Hematology, Division of Cardiovascular Diseases, and Department of Radiology, Division of Nuclear Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Rodney H FalkCardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Victor A FerrariPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Marianna FontanaDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Olivier GheysensNuclear Medicine and Molecular Imaging, University Hospitals Leuven, Leuven, Belgium.
Julian D GillmoreDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Mazen A HannaDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Bouke P C HazenbergDepartment of Rheumatology & Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Arnt V KristenDepartment of Cardiology, University of Heidelberg, Heidelberg, Germany.
Raymond Y KwongCardiac Amyloidosis Program, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Mathew S MaurerColumbia University Medical Center/New York Presbyterian Hospital, Columbia University, New York, NY, USA.
Giampaolo MerliniAmyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
Edward J MillerCardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
James C MoonDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Venkatesh L MurthyFrankel Cardiovascular Center, Michigan Medicine, Ann Arbor, MI, USA.
C Cristina QuartaDivision of Medicine, National Amyloidosis Centre, University College London, London, UK.
Claudio RapezziCardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater-University of Bologna, Bologna, Italy.
Frederick L RubergAmyloidosis Center and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
Sanjiv J ShahFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Hein J VerberneDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jamieson M BourqueDepartments of Medicine and Radiology, Cardiovascular Imaging Center, University of Virginia, Charlottesville, VA, USA.
University College London · GBBrigham and Women's Hospital · USUniversity of Groningen · NLBoston University · USCleveland Clinic · USHeidelberg University · DEImaging Center · USKU Leuven · BEKumamoto University · JPMayo Clinic in Arizona · USMichigan Medicine · USNew York Hospital Queens · USNewYork–Presbyterian Hospital · USNorthwestern University · USUniversity Medical Center Groningen · NLUniversity of Amsterdam · NLUniversity of Bologna · ITUniversity of Pavia · ITUniversity of Pennsylvania · USYale University · US

Funding

British Heart Foundation FS/10/40/28260British Heart Foundation FS/12/56/29723British Heart Foundation FS/16/31/32185British Heart Foundation FS/18/21/33447
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31468376
OpenAlexW2970218258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.